Medicare Enrolled
Dr. Jiten Patel, MD
Pulmonary Disease · Spokane, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Jiten Patel is a pulmonary disease specialist in Spokane, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 2,407 Medicare services across 2,263 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $239,453 from 37 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in WA
$239,453 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,407
Medicare services
Top 3% in WA for pulmonary disease
2,263
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~127 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
336 | $41 | $164 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
332 | $41 | $157 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
252 | $20 | $78 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
174 | $96 | $368 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
125 | $25 | $416 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
123 | $4 | $379 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
115 | $122 | $515 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
95 | $30 | $112 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
90 | $51 | $188 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
75 | $26 | $97 |
| Endoscopic destruction of lung airway growth or narrowing A procedure using an endoscope to destroy abnormal growths or relieve narrowing within the lung airways. |
68 | $196 | $826 |
| New patient office visit, complex (60-74 min) | 64 | $163 | $632 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
60 | $95 | $366 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
44 | $130 | $701 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
43 | $41 | $500 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
43 | $134 | $624 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $123 | $479 |
| Lung airway biopsy using endoscope A procedure to remove a small tissue sample from the lung airways using a flexible tube with a camera. The sample is examined to check for disease or abnormalities. |
41 | $24 | $469 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
39 | $113 | $531 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
38 | $74 | $272 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $90 | $341 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $136 | $498 |
| Bronchoscopy A procedure to examine the airways inside the lungs using a thin, flexible tube with a camera. |
23 | $0 | $372 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $67 | $260 |
| Placement of radiation therapy markers in lung airways A procedure where small markers are placed into the airways of the lung using an endoscope to assist with radiation therapy targeting. |
22 | $75 | $556 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $72 | $260 |
| Lung airway stent placement, first stent A stent is placed in the lung airway using an endoscope to keep the airway open. This is the first stent placed during the procedure. |
15 | $65 | $612 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
15 | $10 | $36 |
| Tracheal stent placement via endoscope A stent is inserted into the windpipe using an endoscope to keep the airway open. |
13 | $81 | $657 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
13 | $99 | $370 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
12 | $102 | $373 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
16.5% medium
81.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$239,453
Total received (2018-2024)
Avg $34,208/year across 7 years
Top 0% in WA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$224,862 (93.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,803 (4.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,788 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$38,659
2023
$14,300
2022
$18,021
2021
$18,008
2020
$13,306
2019
$62,016
2018
$75,142
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Actelion Pharmaceuticals US, Inc.
$23,416
Boehringer Ingelheim Pharmaceuticals, Inc.
$7,827
INTUITIVE SURGICAL, INC.
$5,586
Electromed, Inc.
$402
AstraZeneca Pharmaceuticals LP
$354
United Therapeutics Corporation
$263
GlaxoSmithKline, LLC.
$235
Boston Scientific Corporation
$120
SANOFI-AVENTIS U.S. LLC
$95
Philips North America LLC
$74
Takeda Pharmaceuticals U.S.A., Inc.
$63
Regeneron Healthcare Solutions, Inc.
$56
Merck Sharp & Dohme LLC
$52
Mylan Specialty L.P.
$38
GENZYME CORPORATION
$35
Amgen Inc.
$23
Genentech USA, Inc.
$21
Top 3 companies account for 95.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$191,322
Actelion Pharmaceuticals US, Inc.
$23,944
INTUITIVE SURGICAL, INC.
$5,586
Covidien LP
$4,806
Bayer HealthCare Pharmaceuticals Inc.
$4,131
AstraZeneca Pharmaceuticals LP
$1,537
GlaxoSmithKline, LLC.
$1,408
Pulmonx Corporation
$1,313
United Therapeutics Corporation
$1,005
Intuitive Surgical, Inc.
$782
Electromed, Inc.
$601
Grifols USA, LLC
$299
Boston Scientific Corporation
$272
Regeneron Healthcare Solutions, Inc.
$233
SANOFI-AVENTIS U.S. LLC
$186
Mylan Specialty L.P.
$183
Insmed, Inc.
$183
Genentech USA, Inc.
$173
GENZYME CORPORATION
$166
Baxter Healthcare
$159
Galvanize Therapeutics, Inc
$145
Ethicon Inc.
$122
Amgen Inc.
$110
Gilead Sciences, Inc.
$105
Pinnacle Biologics, Inc
$89
Advanced Respiratory, Inc
$80
Merck Sharp & Dohme LLC
$78
Philips North America LLC
$74
Takeda Pharmaceuticals U.S.A., Inc.
$63
PFIZER INC.
$62
Cook Medical LLC
$56
Sunovion Pharmaceuticals Inc.
$49
ADVANCED RESPIRATORY, INC
$36
Philips Electronics North America Corporation
$35
Novartis Pharmaceuticals Corporation
$33
Astellas Pharma US Inc
$18
Medtronic, Inc.
$12
Top 3 companies account for 92.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ALIYA SYSTEM · ANORO · Acquire · Adempas · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · COOK MEDICAL CIAGLIA BLUE RHINO · CRESEMBA · DUPIXENT · Da Vinci Surgical System · ELIQUIS · EXALT Model D · Edge Navigation · Esbriet · FASENRA · GLASSIA · General - Pulmonary · Hillrom - Life 2000 Ventilation System · ILLUMISITE · IMFINZI · LONHALA MAGNAIR · Life 2000 Ventilation System · Monarch Platform · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Photofrin · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · REMODULIN · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · SuperDimension · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The MetaNeb System · The Vest System Model 105 Home Care · The Vest System Model 205 Acute Care · UPTRAVI · UTIBRON · WINREVAIR · XOLAIR · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for pulmonary disease in WA.
Geographic Context
Pulmonary diseases within 10 mi
8
Per 100K population
1.5
County median income
$73,513
Nearest hospital
PROVIDENCE HOLY FAMILY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 3% in WA), with speaking/promotional industry engagement in the top 0% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with pulmonary gas exchange test?
Based on Medicare claims data, Dr. Patel performed 336 pulmonary gas exchange test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $239,453 from 37 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other pulmonary diseases in Spokane?
Dr. Patel's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Spokane
Browse pulmonary diseases in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in WA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in WA
Which WA pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology